Is Sanara Medtech Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: SMTI) stock is to Strong Buy SMTI stock.
Out of 1 analyst, 1 (100%) are recommending SMTI as a Strong Buy, 0 (0%) are recommending SMTI as a Buy, 0 (0%) are recommending SMTI as a Hold, 0 (0%) are recommending SMTI as a Sell, and 0 (0%) are recommending SMTI as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year SMTI price target, the average SMTI price target is $44.00, with the highest SMTI stock price forecast at $44.00 and the lowest SMTI stock price forecast at $44.00.
The Wall Street analyst predicted that Sanara Medtech's share price could reach $44.00 by Mar 27, 2025. The average Sanara Medtech stock price prediction forecasts a potential upside of 36.6% from the current SMTI share price of $32.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.